StockData
CVRx, Inc. logo

CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.53−0.07 (-11.77%)

Close on Nov 19, 2026Market cap $14.20MP/E –Yield –

CVRx free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

CVRx's free cash flow for the twelve months ending Jun 30, 2026 was -$41.05M. For fiscal 2025 it was -$40.75M. The highest annual figure on record is -$16.41M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$40.75M–
FY2024Dec 31, 2024-$40.51M–
FY2023Dec 31, 2023-$39.61M–
FY2022Dec 31, 2022-$43.36M–
FY2021Dec 31, 2021-$28.92M–
FY2020Dec 31, 2020-$16.41M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.94M–
Q1 FY2026Mar 31, 2026-$12.29M–
Q4 FY2025Dec 31, 2025-$9.83M–
Q3 FY2025Sep 30, 2025-$10.00M–
Q2 FY2025Jun 30, 2025-$8.04M–
Q1 FY2025Mar 31, 2025-$12.88M–
Q4 FY2024Dec 31, 2024-$8.06M–
Q3 FY2024Sep 30, 2024-$10.45M–
Q2 FY2024Jun 30, 2024-$10.19M–
Q1 FY2024Mar 31, 2024-$11.81M–
Q4 FY2023Dec 31, 2023-$8.01M–
Q3 FY2023Sep 30, 2023-$8.16M–
Q2 FY2023Jun 30, 2023-$12.95M–
Q1 FY2023Mar 31, 2023-$10.49M–
Q4 FY2022Dec 31, 2022-$10.92M–
Q3 FY2022Sep 30, 2022-$11.36M–
Q2 FY2022Jun 30, 2022-$10.15M–
Q1 FY2022Mar 31, 2022-$10.94M–
Q4 FY2021Dec 31, 2021-$7.55M–
Q3 FY2021Sep 30, 2021-$9.38M–
Q2 FY2021Jun 30, 2021-$6.84M–
Q1 FY2021Mar 31, 2021-$5.14M–
Q4 FY2020Dec 31, 2020-$4.19M–
Q3 FY2020Sep 30, 2020-$5.28M–

More CVRx figures

See a number that looks wrong?